CCXI - ChemoCentryx, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
7.72
-0.17 (-2.15%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close7.89
Open7.94
Bid0.00 x 0
Ask0.00 x 0
Day's Range7.63 - 8.05
52 Week Range5.52 - 10.80
Volume105,274
Avg. Volume186,370
Market Cap376.02M
Beta1.80
PE Ratio (TTM)-12.37
EPS (TTM)-0.62
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.00
Trade prices are not sourced from all markets
  • Capital Cube20 hours ago

    ETFs with exposure to ChemoCentryx, Inc. : October 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ChemoCentryx, Inc. Here are 5 ETFs with the largest exposure to CCXI-US. Comparing the performance and risk of ChemoCentryx, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017
    Capital Cube13 days ago

    ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017

    Categories: Yahoo FinanceGet free summary analysis ChemoCentryx, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 8.94 million, Net Earnings of USD -9.24 million. Change in operating cash flow of -121.02% compared to same period last year is about the same as change in earnings, likely no significant movement ... Read more (Read more...)

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : October 3, 2017
    Capital Cube14 days ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : October 3, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • All You Need To Know About ChemoCentryx Inc’s (CCXI) Risks
    Simply Wall St.15 days ago

    All You Need To Know About ChemoCentryx Inc’s (CCXI) Risks

    If you are looking to invest in ChemoCentryx Inc’s (NASDAQ:CCXI), or currently own the stock, then you need to understand its beta in order to understand how it can affectRead More...

  • Is There Now An Opportunity In ChemoCentryx Inc (CCXI)?
    Simply Wall St.last month

    Is There Now An Opportunity In ChemoCentryx Inc (CCXI)?

    ChemoCentryx Inc (NASDAQ:CCXI), a pharmaceuticals, biotechnology and life sciences company based in United States, saw a decent share price growth in the teens level on the NasdaqGS over the lastRead More...

  • GlobeNewswirelast month

    ChemoCentryx to Present at Three Upcoming Investor Conferences

    MOUNTAIN VIEW, Calif., Sept. 05, 2017-- ChemoCentryx, Inc.,, a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer, today announced that Thomas ...

  • Capital Cube2 months ago

    ChemoCentryx, Inc. – Value Analysis (NASDAQ:CCXI) : August 21, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives ChemoCentryx, Inc. a score of 21. Our analysis is based on comparing ChemoCentryx, Inc. with the following peers – Fortress Biotech, Inc., Biogen Inc., Johnson & Johnson, AbbVie, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Pfizer Inc. and ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of CCXI earnings conference call or presentation 8-Aug-17 9:00pm GMT

    Q2 2017 ChemoCentryx Inc Earnings Call

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bearish Manner : CCXI-US : August 10, 2017
    Capital Cube2 months ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bearish Manner : CCXI-US : August 10, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Associated Press2 months ago

    ChemoCentryx reports 2Q loss

    The Mountain View, California-based company said it had a loss of 19 cents per share. The biopharmaceutical company posted revenue of $8.9 million in the period. ChemoCentryx shares have climbed 37 percent ...

  • GlobeNewswire2 months ago

    ChemoCentryx Reports Second Quarter 2017 Financial Results and Recent Highlights

    --Pivotal Phase III ADVOCATE trial of avacopan on track to complete enrollment in mid-2018 as projected--. --Launching second trial of avacopan in patients with C3 Glomerulopathy--. --Conference call today ...

  • ACCESSWIRE2 months ago

    Investor Network: Chemocentryx, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 8, 2017 / Chemocentryx, Inc. (NASDAQ: CCXI ) will be discussing their earnings results in their Q2 Earnings Call to be held on Tuesday, August 8, 2017 at 5:00 PM Eastern ...

  • GlobeNewswire3 months ago

    ChemoCentryx to Hold Second Quarter 2017 Financial Results Conference Call on Tuesday, August 8, 2017

    MOUNTAIN VIEW, Calif., July 26, 2017-- ChemoCentryx, Inc.,, a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer, today announced that the ...

  • New Strong Buy Stocks for July 18th
    Zacks3 months ago

    New Strong Buy Stocks for July 18th

    New Strong Buy Stocks for July 18th

  • ChemoCentryx (CCXI) Catches Eye: Stock Moves Up 6.4%
    Zacks3 months ago

    ChemoCentryx (CCXI) Catches Eye: Stock Moves Up 6.4%

    ChemoCentryx, Inc. (CCXI) moved big last session, as its shares rose over 6% on the day.

  • Capital Cube4 months ago

    ETFs with exposure to ChemoCentryx, Inc. : June 15, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ChemoCentryx, Inc. Here are 5 ETFs with the largest exposure to CCXI-US. Comparing the performance and risk of ChemoCentryx, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : June 8, 2017
    Capital Cube4 months ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : June 8, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of CCXI earnings conference call or presentation 10-May-17 9:00pm GMT

    Q1 2017 ChemoCentryx Inc Earnings Call

  • Capital Cube5 months ago

    ChemoCentryx, Inc. – Value Analysis (NASDAQ:CCXI) : May 15, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives ChemoCentryx, Inc. a score of 21. Our analysis is based on comparing ChemoCentryx, Inc. with the following peers – Fortress Biotech, Inc., Biogen Inc., Johnson & Johnson, AbbVie, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Pfizer Inc. and ... Read more (Read more...)

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : May 12, 2017
    Capital Cube5 months ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : May 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • Associated Press5 months ago

    ChemoCentryx reports 1Q loss

    On a per-share basis, the Mountain View, California-based company said it had a loss of 12 cents. The biopharmaceutical company posted revenue of $8.2 million in the period. ChemoCentryx shares have dropped ...